145 related articles for article (PubMed ID: 11834512)
1. Natriuretic peptide gene expression in DOCA-salt hypertension after blockade of type B endothelin receptor.
Bianciotti LG; de Bold AJ
Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H1127-34. PubMed ID: 11834512
[TBL] [Abstract][Full Text] [Related]
2. Effect of selective ET(A) receptor blockade on natriuretic peptide gene expression in DOCA-salt hypertension.
Bianciotti LG; De Bold AJ
Am J Physiol Heart Circ Physiol; 2000 Jul; 279(1):H93-H101. PubMed ID: 10899045
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.
Bianciotti LG; de Bold AJ
Cardiovasc Res; 2001 Mar; 49(4):808-16. PubMed ID: 11230980
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
Rothermund L; Vetter R; Dieterich M; Kossmehl P; Gögebakan O; Yagil C; Yagil Y; Kreutz R
Circulation; 2002 Oct; 106(18):2305-8. PubMed ID: 12403658
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats.
Yokota N; Bruneau BG; Fernandez BE; de Bold ML; Piazza LA; Eid H; de Bold AJ
Am J Hypertens; 1995 Mar; 8(3):301-10. PubMed ID: 7540847
[TBL] [Abstract][Full Text] [Related]
6. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Ammarguellat F; Larouche I; Schiffrin EL
Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
8. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
Ehmke H; Faulhaber J; Münter K; Kirchengast M; Wiesner RJ
Hypertension; 1999 Apr; 33(4):954-60. PubMed ID: 10205230
[TBL] [Abstract][Full Text] [Related]
9. Regulation of aortic atrial natriuretic factor and angiotensinogen in experimental hypertension.
Ogawa T; Linz W; Schölkens BA; de Bold AJ
J Cardiovasc Pharmacol; 1998 Dec; 32(6):1001-8. PubMed ID: 9869508
[TBL] [Abstract][Full Text] [Related]
10. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
Johnson RJ; Galligan JJ; Fink GD
J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic factor and brain natriuretic peptide gene expression in the spontaneous hypertensive rat during postnatal development.
Kuroski de Bold ML
Am J Hypertens; 1998 Aug; 11(8 Pt 1):1006-18. PubMed ID: 9715795
[TBL] [Abstract][Full Text] [Related]
12. Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism.
Larouche I; Schiffrin EL
Hypertension; 1999 Oct; 34(4 Pt 2):795-801. PubMed ID: 10523363
[TBL] [Abstract][Full Text] [Related]
13. Variable renal atrial natriuretic factor gene expression in hypertension.
Ogawa T; Linz W; Schölkens BA; de Bold AJ
Hypertension; 1999 Jun; 33(6):1342-7. PubMed ID: 10373213
[TBL] [Abstract][Full Text] [Related]
14. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Allcock GH; Venema RC; Pollock DM
Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
[TBL] [Abstract][Full Text] [Related]
16. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
[TBL] [Abstract][Full Text] [Related]
17. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
[TBL] [Abstract][Full Text] [Related]
18. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
Giulumian AD; Pollock DM; Clarke N; Fuchs LC
Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
[TBL] [Abstract][Full Text] [Related]
19. Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension.
Matsumura Y; Kuro T; Kobayashi Y; Konishi F; Takaoka M; Wessale JL; Opgenorth TJ; Gariepy CE; Yanagisawa M
Circulation; 2000 Nov; 102(22):2765-73. PubMed ID: 11094045
[TBL] [Abstract][Full Text] [Related]
20. [The changes in natriuretic peptide receptors (NP-R) in the lung and kidney in DOCA-salt hypertensive rats].
Liu LM; Yoshimi T
Nihon Naibunpi Gakkai Zasshi; 1995 May; 71(4):587-96. PubMed ID: 7796923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
